Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus

Cites (345)

Items 201–345 of 345

1. Effect of metformin on insulin receptor binding and glycaemic control in type II diabetes.
   Janet M. Lord, S.I. White, Clifford J. Bailey, Terence William Atkins, Ronald F. Fletcher, K. G. Taylor · 1983 · BMJ
2. Targeting hyperglycaemia with either metformin or repaglinide in non‐obese patients with type 2 diabetes: results from a randomized crossover trial
   Søren Søgaard Lund, Lise Tarnow, Coen D.A. Stehouwer, Caspar Schalkwijk, M. Frandsen, U. Smidt, Oluf Borbye Pedersen, H.‐H. Parving, Allan Arthur Vaag · 2007 · Diabetes Obesity and Metabolism
3. The Effects of Dexfenfluramine on Blood Glucose Control in Patients with Type 2 Diabetes
   Karen A. Willey, Lynda M. Molyneaux, Jane Overland, Dennis K. Yue · 1992 · Diabetic Medicine
4. Metformin prolongs the postprandial fall in plasma ghrelin concentrations in type 2 diabetes
   Patrick English, A. Ashcroft, Michael Patterson, Terence M. Dovey, Jason C. G. Halford, James Harrison, D. Eccleston, Stephen Robert Bloom, Mohammad A. Ghatei, John P.H. Wilding · 2006 · Diabetes/Metabolism Research and Reviews
5. Comparative Effects of Glibenclamide and Metformin on Ambulatory Blood Pressure and Cardiovascular Reactivity in NIDDM
   Puma Sundaresan, Denise Lykos, Ali Daher, Terence Diamond, Richard Morris, Laurence Guy Howes · 1997 · Diabetes Care
6. Metformin Normalizes Insulin Binding to Monocytes from Obese Nondiabetic Subjects and Obese Type II Diabetic Patients
   Vincenzo Trischitta, Damiano Gullo, VINCENZO PEZZINO, Riccardo Vigneri · 1983 · The Journal of Clinical Endocrinology & Metabolism
7. The Effects of Metformin on Adipocyte Insulin Action and Metabolic Control in Obese Subjects with Type 2 Diabetes
   Oluf Pedersen, O. Hother Nielsen, J. F. Bak · 1989 · Diabetic Medicine
8. Efficacy and tolerability of initial combination therapy with nateglinide and metformin in treatment-naïve patients with type 2 diabetes
   Edward S. Horton, James Edward Foley, Sharon G. Shen, Michelle A. Baron · 2004 · Current Medical Research and Opinion
9. Evaluation of the Importance of Maternal History of Diabetes and of Mitochondrial Variation in the Development of NIDDM
   Mark I. McCarthy, P. Cassell, T. Tran, L. Mathias, Leen M. ‘t Hart, J. Antonie Maassen, C. Snehalatha, A. Ramachandran, M. Viswanathan, G. A. Hitman · 1996 · Diabetic Medicine
10. Determination of Plasma Metformin by a New Cation-Exchange HPLC Technique
    Anna Rita Bonfigli, Silvana Manfrini, Franco Gregorio · 1999 · Therapeutic Drug Monitoring
11. Short‐term effects of metformin in type 2 diabetes
    Annika Westin Eriksson, Stig Attvall, M. Bonnier, Jan W. Eriksson, B. Rosander, F. Anders Karlsson · 2006 · Diabetes Obesity and Metabolism
12. Biguanide related lactic acidosis: incidence and risk factors.
    C Aguilar, A Reza, Juan Emilio Tumbaco Garcia, Juan A Rull · 1992 · PubMed
13. Circadian Variation of Glucose, Insulin, and Free Fatty Acids During Long-term Use of Oral Hypoglycaemic Agents in Diabetes Mellitus
    A. N. Rigas, Alan Holland Bittles, David R. Hadden · 1968 · BMJ
14. Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profiles
    L. S. Hermann, J -E. Karlsson, �. Sj�strand · 1991 · European Journal of Clinical Pharmacology
15. Changes in liver tests during 1‐year treatment of patients with Type 2 diabetes with pioglitazone, metformin or gliclazide
    Glyn Belcher, Guntram Schernthaner · 2005 · Diabetic Medicine
16. Comparative three-month study of the efficacies of metformin and gliclazide in the treatment of NIDD.
    J Noury, A Nandeuil · 1991 · PubMed
17. Metabolic and haemodynamic effects of metformin in patients with type 2 diabetes mellitus and hypertension
    Marcelo Hiroshi Uehara, Nárcia E. B. Kohlmann, Maria Teresa Zanella, Sandra Roberta G. Ferreira · 2001 · Diabetes Obesity and Metabolism
18. Repaglinide in combination therapy with metformin in Type 2 diabetes
    R Moses · 2009 · Experimental and Clinical Endocrinology & Diabetes
19. Effect of metformin plus roziglitazone compared with metformin alone on glycaemic control in well‐controlled Type 2 diabetes
    Murray W Stewart, Deborah T. Cirkel, Kristian Furuseth, Jill Donaldson, N. Biswas, M. Starkie, Costas Phenekos, Andreas Hamann · 2006 · Diabetic Medicine
20. Monotherapy with Metformin: Does It Improve Hypoxia in Type 2 Diabetic Patients?
    Vladan Ćosić, Slobodan Antić, Milica Pesić, Olivera Jovanović, Slavica Kundalić, Vidosava B. Djordjević · 2001 · Clinical Chemistry and Laboratory Medicine (CCLM)
21. Comparative efficacy of glimepiride and/or metformin with insulin in type 2 diabetes
    Udaya M. Kabadi, Mary U. Kabadi · 2006 · Diabetes Research and Clinical Practice
22. Comparison of the Effects of Pioglitazone and Metformin on Insulin Resistance and Hormonal Markers in Patients with Impaired Glucose Tolerance and Early Diabetes
    Kazuo EGUCHI, Hidenori Tomizawa, Joji Ishikawa, Satoshi Hoshide, Toshio Numao, Toshio Fukuda, Kazuyuki Shimada, Kazuomi Kario · 2007 · Hypertension Research
23. Metformin Plus Low-Dose Glimeperide Significantly Improves Homeostasis Model Assessment for Insulin Resistance (HOMAIR) and β-Cell Function (HOMAβ-cell) Without Hyperinsulinemia in Patients With Type 2 Diabetes Mellitus
    Valmore Bermúdez, Clímaco Cano, Mayerlim T. Medina, Aida J. Souki, Miguel A Lemus, Elliuz Leal, Hamid Seyfi, Raquel Cano, Ana Ciscek, Fernando Bermúdez Arias et al. · 2007 · American Journal of Therapeutics
24. Metformin reduces post-prandial insulin needs in type I (insulin-dependent) diabetic patients: Assessment by the artificial pancreas
    Henri Gin, G. Slama, P Weissbrodt, Thierry Poynard, Patrick Vexiau, J.C. Klein, Georges Tchobroutsky · 1982 · Diabetologia
25. A comparison of preconstituted, fixed combinations of low-dose glyburide plus metformin versus high-dose glyburide alone in the treatment of type 2 diabetic patients
    Giuseppe Erle, S. Lovise, C. Stocchiero · 1999 · Acta Diabetologica
26. Metformin and Lactic Acidosis: Guilt by association?
    Peter W. Stacpoole · 1998 · Diabetes Care
27. The Effect of Metformin on Adipose Tissue Metabolism and Peripheral Blood Flow in Subjects With NIDDM
    Per‐Anders Jansson, H Soffia Gudbjörnsdóttir, Ove K. Andersson, Peter Lönnroth · 1996 · Diabetes Care
28. One‐year Acarbose Treatment Raises Fasting Serum Acetate in Diabetic Patients
    Thomas M. S. Wolever, R. Radmard, J L Chiasson, John A. Hunt, Robert G. Josse, Carol Palmason, N. Wilson Rodger, S. Ross, Edmond A. Ryan, Meng Hee Tan · 1995 · Diabetic Medicine
29. Intensive insulin therapy combined with metformin in obese type 2 diabetec patients
    Andreas Fritsche, R.-M. Schmülling, Hans‐Ulrich Häring, Michael Stümvoll · 2000 · Acta Diabetologica
30. Low dose metformin in the treatment of type II non-insulin-dependent diabetes: Clinical and metabolic evaluations
    Franco Gregorio, Franca Ambrosi, Piero Marchetti, Sonia Cristallini, Renzo Navalesi, Paolo Brunetti, Paolo Filipponi · 1990 · Acta Diabetologica
31. Metformin Increases Blood Flow and Forearm Glucose Uptake in a Group of Non-obese Type 2 Diabetes Patients
    Flávio de Castro Magalhães, L. Gouveia, Maria Teresa da Costa Gonçalves Torquato · 2006 · Hormone and Metabolic Research
32. Outcome of Metformin-Facilitated Reinitiation of Oral Diabetic Therapy in Insulin-Treated Patients with Non-Insulin-Dependent Diabetes Mellitus
    David S.H. Bell, Matthew S. Mayo · 1997 · Endocrine Practice
33. COMBINED METFORMIN-CHLORPROPAMIDE THERAPY IN 108 DIABETIC SULPHONYLUREA-FAILURES
    B F Clarke, L. J. P. Duncan · 1965 · The Lancet
34. Rosiglitazone Treatment Increases Subcutaneous Adipose Tissue Glucose Uptake in Parallel with Perfusion in Patients with Type 2 Diabetes: A Double-Blind, Randomized Study with Metformin
    Antti P. M. Viljanen, Kirsi A. Virtanen, Mikko J. Järvisalo, Kirsti Hällsten, Riitta K Parkkola, Tapani Rönnemaa, Fredrik Lönnqvist, Patricia Iozzo, Ele Ferrannini, Pirjo Nuutila · 2005 · The Journal of Clinical Endocrinology & Metabolism
35. Comparison between acarbose, metformin, and insulin treatment in type 2 diabetic patients with secondary failure to sulfonylurea treatment.
    Alfonso L. Calle‐Pascual, J Garcia-Honduvilla, P J Martin-Alvarez · 1995 · PubMed
36. Metformin added to insulin therapy in poorly controlled type 2 diabetes.
    Irl B. Hirsch · 1999 · Diabetes Care
37. Does metformin decrease blood pressure in patients with Type 2 diabetes intensively treated with insulin?
    Wulffelé, M. G., Kooy, A., Lehert, P., Bets, D., Donker, A. J. M., Stehouwer, C. D. A. · 2005 · Diabetic Medicine
38. Changes in insulin receptor tyrosine kinase activity associated with metformin treatment of type 2 diabetes.
    R. F. Santos, R Nomizo, B. L. Wajhenberg, Gerald M. Reaven, Salman Azhar · 1995 · PubMed
39. Metformin treatment in NIDDM patients with mild renal impairment
    VM Connolly, Colin M Kesson · 1996 · Postgraduate Medical Journal
40. Clinical experience with acarbose: results of a Canadian multicentre study.
    N. Wilson Rodger, J.-L. Chiasson, R G Josse · 1995 · PubMed
41. Obese Patients with Type 2 Diabetes Poorly Controlled by Insulin and Metformin: Effects of Adjunctive Dexfenfluramine Therapy on Glycaemic Control
    Karen A. Willey, Lynda M. Molyneaux, Dennis K. Yue · 1994 · Diabetic Medicine
42. The hyperlactatemic effect of biguanides: a comparison between phenformin and metformin during a 6-month treatment.
    Paolo Cavallo‐Perin, Enzo Aluffi, P Estivi · 1989 · PubMed
43. Treatment strategies for secondary sulfonylurea failure. Should we start insulin or add metformin? Is there a place for intermittent insulin therapy?
    Leif Groop, Elisabeth Widén · 1991 · PubMed
44. Sulfonylurea-metformin-combination versus sulfonylurea-insulin-combination in secondary failures of sulfonylurea monotherapy. Results of a prospective randomized study in 50 patients.
    W Klein · 1991 · PubMed
45. No Relationship Between Carbohydrate Intake and Effect of Acarbose on HbA1c or Gastrointestinal Symptoms in Type 2 Diabetic Subjects Consuming 30–60% of Energy From Carbohydrate
    Thomas M. S. Wolever, Jean‐Louis Chiasson, Robert G. Josse · 1998 · Diabetes Care
46. Comparison of Glargine Insulin Versus Rosiglitazone Addition in Poorly Controlled Type 2 Diabetic Patients on Metformin Plus Sulfonylurea
    Curtis L. Triplitt, Leonard C. Glass, Yoshiniro Miyazaki, Estela Wajcberg, Amalia Gastaldelli, Eleanna De Filippis, Eugênio Cersósimo, Ralph A. DeFronzo · 2006 · Diabetes Care
47. The influence of dimethylbiguanide on phenprocoumon elimination and its mode of action
    E. E. Ohnhaus, W Berger, François Duckert · 1983 · Journal of Molecular Medicine
48. Efficacy of combined treatments in NIDDM patients with secondary failure to sulphonylureas. Is it predictable?
    Vincenzo Trischitta, S. Italia, Massimo Raimondo, Vincenzo Guardabasso, Carmelo Licciardello, F. Runello, Stefano Mazzarino, L. Sangiorgi, Marcello Anello, Riccardo Vigneri · 1998 · Journal of Endocrinological Investigation
49. Metformin in Treatment of Diabetes Mellitus
    B. Gottlieb, William Auld · 1962 · BMJ
50. Effects of metformin on fibrinogen levels in obese patients with type 2 diabetes.
    Guillermo Fanghänel, U Silva, Leticia Sánchez‐Reyes, D Sisson, David A. Sotres, Torres Em · 1998 · PubMed
51. Comparative efficacy of metformin and glibenclamide in patients with non-insulin-dependent diabetes mellitus.
    L. S. Hermann, P.‐O. Bitzén, Thomas Kjellström, Folke Lindgärde, Bengt Scherstén · 1991 · PubMed
52. Effects of improved glycaemic control on calcium and magnesium homeostasis in type II diabetes.
    Alasdair M. McBain, I. R. F. Brown, D. G. Menzies · 1988 · Journal of Clinical Pathology
53. Acarbose for the treatment of Type II diabetes: the results of a Canadian multi-centre trial
    Robert G. Josse · 1995 · Diabetes Research and Clinical Practice
54. Effects of metformin on the glycemic control, lipid profile, and arterial blood pressure of type 2 diabetic patients with metabolic syndrome already on insulin
    Carlos Alberto Mourão Júnior, João Roberto de Sá, Olívia M. Silveira Guedes, Sérgio Atala Dib · 2006 · Brazilian Journal of Medical and Biological Research
55. Irreversibility of the Defect in Glycogen Synthase Activity in Skeletal Muscle From Obese Patients With NIDDM Treated With Diet and Metformin
    Peter Damsbo, Leif Sparre Hermann, Allan Arthur Vaag, Ole Hother Nielsen, Henning Beck‐Nielsen · 1998 · Diabetes Care
56. Choice of treatment affects plasma levels of insulin-like growth factor-binding protein-1 in noninsulin-dependent diabetes mellitus.
    Martin Gibson, Melissa Westwood, Steven R. Crosby · 1995 · The Journal of Clinical Endocrinology & Metabolism
57. Both slow-release and regular-form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus
    Chang‐Hsun Hsieh, Chih-Tseung He, Chien-Hsing Lee, Ling‐Yi Wu, Yi‐Jen Hung · 2007 · Metabolism
58. Metformin Reduces Circulating Factor VII Concentrations in Patients with Type 2 Diabetes mellitus
    Peter Grant · 1998 · Thrombosis and Haemostasis
59. Relationship between plasminogen activator inhibitor type-1 plasma levels and the lipoprotein(a) concentrations in non-insulin-dependent diabetes mellitus
    Roberto Testa, Anna Rita Bonfigli, LUCIO PIANTANELLI · 1996 · Diabetes Research and Clinical Practice
60. Long-term Effect of Glimepiride and Rosiglitazone on Non-conventional Cardiovascular Risk Factors in Metformin-treated Patients Affected by Metabolic Syndrome: A Randomized, Double-blind Clinical Trial
    Giuseppe Derosa, Av Gaddi, Leonardina Ciccarelli · 2005 · Journal of International Medical Research
61. Prospective randomized two-years clinical study comparing additional metformin treatment with reducing diet in type 2 diabetes.
    B Teupe, K. Bergis · 1991 · PubMed
62. Rosiglitazone plus metformin is effective and well tolerated in clinical practice: results from large observational studies in people with type 2 diabetes
    Ch. Rosak, R. Petzoldt, R. Wolf · 2005 · International Journal of Clinical Practice
63. A retrospective chart review of uncontrolled use of metformin as an add-on therapy in type 2 diabetes
    Mary Lynn Johnson, Arthur Krosnick, Patricia Carson, Ann Marie McDade, Karen Laraway · 1998 · Clinical Therapeutics
64. Glucose intolerance and associated factors in the Fergana Valley, Uzbekistan
    H. King, Б. П. Абдуллаев, Stora Djumaeva, V. Nikitin, L. Ashworth, M. Dobó · 1998 · Diabetic Medicine
65. Long‐term effects of pioglitazone and metformin on insulin sensitivity in patients with Type 2 diabetes mellitus
    Michael Roden, Markku Laakso, Don Johns, Mario Widel, Richard Urquhart, C. Richardson, Segundo Mariz, Meng Hee Tan · 2005 · Diabetic Medicine
66. THE EFFECT OF METFORMIN ON WEIGHT LOSS IN OBESITY
    Jørgen Pedersen · 1965 · European Journal of Endocrinology
67. Effects of metformin and glibenclamide alone and in combination on serum lipids and lipoproteins in patients with non-insulin-dependent diabetes mellitus.
    L. S. Hermann, Thomas Kjellström, Peter Nilsson‐Ehle · 1991 · PubMed
68. Treatment of non-insulin-dependent diabetes mellitus with metformin.
    Robert M. Guthrie · 1997 · PubMed
69. A double‐blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes 1
    Philip Home, Clifford J. Bailey, Jill Donaldson, H. Chen, Murray W Stewart · 2007 · Diabetic Medicine
70. Plasma t-PA and PAI-1 Antigen Concentrations in Non-Insulin Dependent Diabetic Patients: Effects of Treatment Modality on Fibrinolysis
    Yong W. Cho, Dong Ho Yang, Do Yon Oh · 1992 · The Korean Journal of Internal Medicine
71. Treatment of NIDDM patients with secondary failure to glyburide: comparison of the addition of either metformin or bed-time NPH insulin to glyburide.
    Riccardo Vigneri, Vincenzo Trischitta, S Italia, Stefano Mazzarino, Agata Maria Rabuazzo, Sebastiano Squatrito · 1991 · PubMed
72. Energy expenditure in non-insulin dependent diabetic subjects on metformin or sulphonylurea therapy
    Peter J. Leslie, R. T. Jung, T E Isles, J. David Baty · 1987 · Clinical Science
73. Evaluation of efficacy and safety of fixed dose combination of glimepiride 2 mg pluspioglitazone 15 mg plus metformin SR 500 mg in the management of patients with type-2 diabetes mellitus.
    D M Meshram, Deepak Langade, Satish B Kinagi · 2005 · PubMed
74. A comparison of treatment with metformin and gliclazide in patients with non-insulin-dependent diabetes
    Lawrence G. McAlpine, Christopher McAlpine, Eugene Waclawski, Andrew Storer, Jim Kay, Brian M. Frier · 1988 · European Journal of Clinical Pharmacology
75. Metformin-Induced Lacticacidemia in Patients with Type 2 Diabetes Mellitus
    Ali A. Abbasi, Kasmikha Riyadh, Dan G. Sotingeanu · 2000 · Endocrine Practice
76. Metabolic Control in Diabetic Subjects in Three Swedish Areas With High, Medium, and Low Sales of Antidiabetic Drugs
    Jan Stålhammar, Ulf Bergman, Kurt Boman · 1991 · Diabetes Care
77. Metformin and Insulin: Is There a Role for Combination Therapy?
    Jacqueline R Daniel, Kathleen O Hagmeyer · 1997 · Annals of Pharmacotherapy
78. Influence of phenformin and metformin on exercise induced lactataemia in patients with diabetes mellitus
    Per Bj�rntorp, S. Carlstr�m, Sven Fagerberg · 1978 · Diabetologia
79. Miglitol, an α-glucosidase inhibitor, prevents the metformin-induced fall in serum folate and vitamin B12 in subjects with type 2 diabetes
    Thomas M. S. Wolever, Lila. Assiff, Tapan K. Basu et al. · 2000 · Nutrition Research
80. Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III study
    Andrew J. Lewin, Robert S. Lipetz, Jacqueline Wu · 2007 · Clinical Therapeutics
81. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
    Salwa W. Rizkalla, Fabienne Elgrably, Georges Tchobroutsky, G. Slama · 1986 · PubMed
82. DOUBLE‐BLIND TRIAL OF METFORMIN IN THE THERAPY OF NONKETOTIC DIABETICS
    Linda Higginbotham, F. I. R. Martin · 1979 · The Medical Journal of Australia
83. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    S Vannasaeng, Sirirat Ploybutr, Wannee Nitiyanant · 1995 · PubMed
84. The Relation of Fetal Growth to Insulin Secretion in Young Men
    J. Wills, J.M. Watson, C. N. Hales, D. I. W. Phillips · 1996 · Diabetic Medicine
85. Metformin efficacy and tolerance in obese non-insulin dependent diabetics: a comparison of two dosage schedules
    D. G. Menzies, I W Campbell, Alasdair M. McBain, I. R. F. Brown · 1989 · Current Medical Research and Opinion
86. Acarbose treatment of sulfonylurea-treated non-insulin dependent diabetics. A double-blind cross-over comparison of an alpha-glucosidase inhibitor with metformin.
    Kristian B. Johansen · 1984 · PubMed
87. A comparison of phenformin and metformin in the treatment of maturity onset diabetes.
    Samara Cairns, Stephen Michael Shalet, A J Marshall · 1977 · PubMed
88. Meformin, plasma glucose and free fatty acids in type II diabetic out-patients: results of a clinical study
    F Gregorio, F Ambrosi, S. Manfrini, Annalisa Santucci, Paolo Filipponi · 1997 · Diabetes Research and Clinical Practice
89. Insulin, glibenclamide or metformin treatment for non insulin dependent diabetes: heterogenous responses of standard measures of insulin action and insulin secretion before and after differing hypoglycaemic therapy.
    K Boyd, Carlyle Rogers, C. A. G. Boreham · 1992 · PubMed
90. Metabolic Effects of Glucocorticoid and Ethanol Administration in Phenformin‐ and Metformin‐Treated Obese Diabetics
    Ove B. Schaffalitzky de Muckadell, Henrik Bindesbøl Mortensen, JENS LYNGSØE · 1979 · Acta Medica Scandinavica
91. METFORMIN COMPARED WITH TOLBUTAMIDE IN THE TREATMENT OF MATURITY‐ONSET DIABETES MELLITUS
    P. Lim, O. T. Khoo · 1970 · The Medical Journal of Australia
92. A Comparison of Metformin Versus Guar in Combination with Sulphonylureas in the Treatment of Non Insulin Dependent Diabetes
    J. Wilson, Mary Scott, Robert E. Gray · 1989 · Hormone and Metabolic Research
93. Ciclazindol: An oral agent with weight reducing properties and hypoglycaemic activity
    M. E. J. Lean, L J Borthwick · 1983 · European Journal of Clinical Pharmacology
94. Troglitazone or metformin in combination with sulfonylureas for patients with type 2 diabetes?
    Kirk Jk, Pearce Ka, Robert Michielutte · 1999 · PubMed
95. Influence of metformin on arginine-induced glucagon secretion in human diabetes.
    Carpentier Jl, Luyckx As, Pierre J. Lefèbvre · 1975 · PubMed
96. The effects of oral hypoglycaemic drugs on serum lipids and lipoproteins in non-insulin-dependent diabetes (NIDDM).
    Elkeles Rs · 1991 · PubMed
97. Metformin and clofibrate in maturity onset diabetes mellitus: advantages of combined treatment.
    S R De Silva, D. JOHN BETTERIDGE, J E Shawe · 1979 · PubMed
98. Beta-cell response to metformin-glibenclamide combination tablets (Glucovance®) in patients with type 2 diabetes
    S. BRUCE, J.-S. Park, Fred T. Fiedorek, H. C. S. Howlett · 2006 · International Journal of Clinical Practice
99. Effect of Oral Antidiabetic Agents on Plasma Amylin Level in Patients with Non-insulin-dependent Diabetes mellitus (Type 2)
    Bożena Zapecka-Dubno, Artur Czyiyk, Anna Dworak · 2011 · Arzneimittelforschung
100. Different effect of acute and chronic oral metformin administration on glucose and insulin response to bread and to pasta in non-insulin dependent diabetic patients
     Michele Lunetta, M. Di Mauro · 1996 · Diabetes Research and Clinical Practice
101. Platelet Behaviour in Non-Insulin-Dependent Diabetes -Influence of Vascular Complications, Treatment and Metabolic Control
     Ian Peacock, Maxine Hawkins, Stan Heptinstall · 1986 · Thrombosis and Haemostasis
102. Combined trial of acetohexamide and two diguanide preparations
     Stephen Szanto · 1964 · Irish Journal of Medical Science (1971 -)
103. Metformin and lipoprotein(a) levels.
     John A. Kiayias, Eugenia D. Vlachou, Elli Papadodima · 1999 · Diabetes Care
104. Safety and efficacy of metformin in a restricted formulary.
     Arthur Swislocki, Quan Khuu, Ellen Liao · 1999 · PubMed
105. Therapeutic Effect of Glibenclamide in a Fixed Combination with Metformin or Phenformin in NIDDM Patients
     Athanasios E. Raptis, Nikolaos A. Tountas, Athanasios Yalouris · 1996 · Hormone and Metabolic Research
106. Effects of metformin treatment on whole-body and splanchnic amino acid turnover in mild type 2 diabetes.
     Paolo Tessari, Gianni Biolo, Daniela Bruttomesso · 1994 · The Journal of Clinical Endocrinology & Metabolism
107. Addition of Benfluorex to Biguanide Improves Glycemic Control in Obese Non–Insulin-Dependent Diabetes
     Patrick Roger, Jean Auclair, Patrice Drain · 1999 · Journal of Diabetes and its Complications
108. Comparison of bedtime NPH insulin or metformin combined with glibenclamide in secondary sulphonylurea failure in obese type II (NIDDM) patients.
     Rauf Niazi, Z Muzaffar · 1998 · PubMed
109. [The risk of lacticate acidosis: a comparison of the 3 biguanides in treatment of diabetics (authors' transl)].
     K Irsigler, H Kritz, H Regal · 1978 · PubMed
110. [Gliclazide and metformin combination in patients with type 2 diabetes. Preliminary data].
     F Galeone, G Fiore, A Arcangeli · 1998 · PubMed
111. Combination daytime chlorpropamide-metformin/bedtime insulin in the treatment of secondary failures in non insulin dependent diabetes.
     C A Aguilar, B Wong, Francisco Javier Gomez-Perez · 1992 · PubMed
112. METFORMIN COMBINED WITH CHLORPROPAMIDE IN THE TREATMENT OF DIABETES MELLITUS.
     J P Bingle, J L JAMES · 1964 · PubMed
113. Efficacy of once- or twice-daily extended release metformin compared with thrice-daily immediate release metformin in type 2 diabetes mellitus.
     Anil Kumar Bhansali, Shariq Rashid Masoodi · 2005 · PubMed
114. [The combination of insulin and metformin in obese patients with type-2 diabetes mellitus].
     M I Sánchez-Barba Izquierdo, J.M. Ibarra Rueda, Ricardo Ruiz de Adana Pérez · 1999 · PubMed
115. Effect of metformin on glycaemic control in type 2 diabetes in daily practice: a retrospective study
     Aline M.E. Stades · 2000 · The Netherlands Journal of Medicine
116. [Effect of biguanide therapy on lactate metabolism during graded submaximal ergometric testing].
     E Pilger, P Schmid, Rolf Goebel · 1978 · PubMed
117. [Body mass index, blood lactate and therapeutic effectiveness of metformin in type II diabetes mellitus].
     F Gregorio, F Ambrosi, F Angelici · 1989 · PubMed
118. [Efficacy and safety of glimepiride plus metformin in a single presentation, as combined therapy, in patients with type 2 diabetes mellitus and secondary failure to glibenclamide, as monotherapy].
     Manuel González-Ortı́z, Esperanza Martínez‐Abundis · 2005 · PubMed
119. [Comparison of two treatment models in type-II diabetic patients with poor metabolic control: Preformed combination of glibenclamide 2,5 mg + metformin 400 mg or mono-therapy with sulfonylurea at maximal doses? An evaluation at six months].
     R D'Argenzio, P Cavallo, Domenico Merante · 1996 · PubMed
120. [Median-term (4 months) treatment with glibenclamide + metformin substituting for glibenclamide + fenformin lowers the lacticemia levels in type-2 diabetics (NIDDM)].
     Mario Velussi, A M Cernigoi, L. Viezzoli · 1992 · PubMed
121. [Treatment of obese diabetic patients using glucophage retard].
     W Munk · 1975 · PubMed
122. [EXPERIENCE WITH THE BIGUANIDE "GLUCOPHAGE"].
     R Puchegger · 1964 · PubMed
123. Metformin as secondary therapy in a defined population with type 2 diabetes
     Jonathan Betz Brown, Kathryn L. Pedula · 1999 · Clinical Therapeutics
124. The effect of metformin on liver blood flow in vivo in normal subjects and patients with non insulin dependent diabetes
     Alberto Signore, Vincenzo Fiore, Marco Chianelli, Enrica Procaccini, Raffaella Barone, Giuseppe Ronga, Marcello Negri, Paolo Pozzilli · 1996 · Diabetes Research and Clinical Practice
125. [Dimethylbiguanide in the treatment of diabetes mellitus].
     G E Allen, D. A. D. Montgomery, Weaver Ja · 1998 · PubMed
126. [Chlorpropamide-metformin in obese diabetics or diabetics with side effects from sulfonylureas. 2-year results].
     M García Viveros, Prado Vega R, J A Rull · 1971 · PubMed
127. Utility of metformin as a non-hormonal agent in the treatment of diabetes mellitus.
     Mehta Bj, Vakil Bj, Narula Dv · 1963 · PubMed
128. [Evaluation of the efficacy of metformin-glibenclamide treatment in overweight non-insulin dependent diabetics].
     Oriana Laurenti, M C Bravi, M. Cassone Faldetta · 1992 · PubMed
129. Dimethyldiguanide in diabetes mellitus; report of a small trial.
     Peter E. Donnelly · 1960 · PubMed
130. [Long-term (3 year) results of the treatment of stable diabetes with low doses of chlopropamide-metformin].
     J Schulte, M García Viveros, Juan A Rull · 1974 · PubMed
131. [Therapy of diabetes mellitus using metformin. Clinical study on 60 patients].
     W Klein, A Herrmann · 1975 · PubMed
132. [Results in the treatment of diabetes with glucophage retard].
     G Beyer · 1975 · PubMed
133. [Long range results (5 years) in the treatment of stable diabetes with low doses of clorpropamide-metformin (author's transl)].
     Haroldo Dies, O Lozano Castañeda, M García Viveros · 1978 · PubMed
134. [Clinical trial with DMBG (Melbin) in diabetes mellitus].
     Y SUGAWARA, Takashi Niimi, Taizo Sato · 1962 · PubMed
135. [Treatment of 81 cases of diabetes mellitus with N,N,dimethyl-biguanide].
     Y Messens, M Margouliès · 1967 · PubMed
136. [Chlorpropamide-dimethylbiguanide combination in the control of diabetes mellitus with complications].
     Reyes Larrasilla Jm · 1970 · PubMed
137. Effects of metformin on plasma glucose, insulin, FFA, glucagon, growth hormone and cortisol responses to oral glucose in subjects with chemical diabetes.
     Dario Giugliano, Roberto Torella, L Improta · 1979 · PubMed
138. [Glycemic equilibrium and weight evolution in diabetics taking metformin].
     F Isnard, P André · 1991 · PubMed
139. [Tolbutamide-dimethyl-biguanide association in the treatment of diabetes mellitus].
     C Bernard, R Bernard · 1965 · PubMed
140. [Blood lactate and biguanide therapy: comparison between phenformin, metformin and buformin in 408 senile diabetics].
     H Bruneder, H J Klein · 1978 · PubMed
141. The effect of metformin on individual amino acid absorption.
     A A Ismail, H.M. Badrawi, S Nasr · 1978 · PubMed
142. [Treatment of diabetes with N,N-dime-thylbiguanide].
     Sandro Muntoni · 1962 · PubMed
143. [Treatment of diabetes by NN-dimethyl biguanide].
     E Azérad, M Lasry · 1960 · PubMed
144. Retrospective Review of Metformin in Inpatients and Outpatients at the University of Michigan
     Hanady M. Sharabash, Tami L. Remington, Peter Mar · 2006 · Diabetes Care
145. Untitled work
     Laffel · 1999 · 10.1002/(sici)1520-7560(199911/12)15:6